78 related articles for article (PubMed ID: 25065965)
1. Cost information of chemotherapy for cervical and endometrial cancer in Japan.
Kamijo Y; Ichikawa M
Jpn J Nurs Sci; 2014 Jul; 11(3):190-9. PubMed ID: 25065965
[TBL] [Abstract][Full Text] [Related]
2. Overall care cost comparison between robotic and laparoscopic surgery for endometrial and cervical cancer.
Desille-Gbaguidi H; Hebert T; Paternotte-Villemagne J; Gaborit C; Rush E; Body G
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):348-52. PubMed ID: 24135382
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan.
Shiroiwa T; Fukuda T; Tsutani K
Clin Ther; 2007 Oct; 29(10):2256-67. PubMed ID: 18042483
[TBL] [Abstract][Full Text] [Related]
4. Involvement of autophagy in cervical, endometrial and ovarian cancer.
Orfanelli T; Jeong JM; Doulaveris G; Holcomb K; Witkin SS
Int J Cancer; 2014 Aug; 135(3):519-28. PubMed ID: 24122662
[TBL] [Abstract][Full Text] [Related]
5. Treatment patterns and economic burden among cervical and endometrial cancer patients newly initiating systemic therapy.
Kebede N; Shah R; Shah A; Corman S; Nwankwo C
Future Oncol; 2022 Mar; 18(8):953-964. PubMed ID: 35094566
[No Abstract] [Full Text] [Related]
6. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
Husseinzadeh N; Husseinzadeh HD
Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer.
Manusirivithaya S; Sripramote M; Tangjitgamol S; Sanjareonsuttikul N; Pisarnturakit P
J Med Assoc Thai; 2005 Aug; 88(8):1035-44. PubMed ID: 16404829
[TBL] [Abstract][Full Text] [Related]
8. Informing health policy in Japan: A mixed-model estimation to compare the cost of illness of cervical cancer and endometrial cancer.
Hayata E; Seto K; Kitazawa T; Matsumoto K; Morita M; Hasegawa T
J Obstet Gynaecol Res; 2016 Apr; 42(4):446-56. PubMed ID: 26712320
[TBL] [Abstract][Full Text] [Related]
9. Decrease in tumor volume and histologic response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma.
Fujiwaki R; Takahashi K; Kitao M
Gynecol Oncol; 1997 May; 65(2):258-64. PubMed ID: 9159335
[TBL] [Abstract][Full Text] [Related]
10. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
Lokich JJ; Moore CL; Anderson NR
Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
Bennett CL; Calhoun EA
Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690
[TBL] [Abstract][Full Text] [Related]
12. [Estimated cost of managing invasive cervical cancer in Tunisia].
Ben Gobrane H; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
Sante Publique; 2009; 21(6):561-9. PubMed ID: 20429226
[TBL] [Abstract][Full Text] [Related]
13. Current status of chemotherapy in gynecologic cancer.
Tropé C; Kristensen G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
[No Abstract] [Full Text] [Related]
14. Practice pattern for postoperative management of endometrial cancer in Japan: a survey of the Japanese Gynecologic Oncology Group.
Watanabe Y; Kitagawa R; Aoki D; Takeuchi S; Sagae S; Sakuragi N; Yaegashi N;
Gynecol Oncol; 2009 Dec; 115(3):456-9. PubMed ID: 19765806
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for gynecologic cancers occurring during pregnancy.
Ko EM; Van Le L
Obstet Gynecol Surv; 2011 May; 66(5):291-8. PubMed ID: 21794193
[TBL] [Abstract][Full Text] [Related]
16. Are supportive care-based treatment strategies preferable to standard chemotherapy in recurrent cervical cancer?
Phippen NT; Leath CA; Miller CR; Lowery WJ; Havrilesky LJ; Barnett JC
Gynecol Oncol; 2013 Aug; 130(2):317-22. PubMed ID: 23707667
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer.
Curtin JP; Shapiro F
Surg Oncol Clin N Am; 1997 Oct; 6(4):813-30. PubMed ID: 9309095
[TBL] [Abstract][Full Text] [Related]
20. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
